Inosiplex for Localized Herpes Zoster in Childhood Cancer Patients: Preliminary Controlled Study

AUTOR(ES)

Feldman, S.

RESUMO

By multiple criteria, inosiplex—a reputed stimulator of virus-sensitized lymphocytes—had no demonstrable therapeutic effects in a preliminary controlled study of patients with localized herpes zoster and cancer. Lymphocytes from the six drug-treated patients were no more responsive to varicella-zoster antigen and phytohemagglutinin than were lymphocytes from seven patients who received a placebo.

Documentos Relacionados

• Evaluation of Topical Polyinosinic Acid-Polycytidylic Acid in Treatment of Localized Herpes Zoster in Children with Cancer: a Randomized, Double-Blind Controlled Study
• Sorivudine versus Acyclovir for Treatment of Dermatomal Herpes Zoster in Human Immunodeficiency Virus-Infected Patients: Results from a Randomized, Controlled Clinical Trial
• Gestalt contact styles in OCD patients: a controlled study
• Risk factors for candidemia in cancer patients: a case-control study.
• Intravenous Penciclovir for Treatment of Herpes Simplex Infections in Immunocompromised Patients: Results of a Multicenter, Acyclovir-Controlled Trial